Results 261 to 270 of about 104,915 (286)

Drug Investigations

2002
openaire   +2 more sources

Expanded Access to Investigational Drugs

New England Journal of Medicine, 2015
Ameet Sarpatwari, Jonathan Darrow, Aaron S Kesselheim   +2 more
exaly  

Investigational drugs for the treatment of cervical cancer

Expert Opinion on Investigational Drugs, 2017
Fabio Barra, Domenica Lorusso, Umberto Leone Roberti Maggiore   +2 more
exaly  

Big physics, small doses: the use of AMS and PET in human microdosing of development drugs

Nature Reviews Drug Discovery, 2003
Graham Lappin
exaly  

Preventing Occupational Exposures to Antineoplastic Drugs in Health Care Settings

Ca-A Cancer Journal for Clinicians, 2006
exaly  

Failure of Investigational Drugs in Late-Stage Clinical Development and Publication of Trial Results

JAMA Internal Medicine, 2016
Thomas J Hwang, Daniel Carpenter, Julie C Lauffenburger   +2 more
exaly  

FDA guidance on co-developing investigational drugs

Nature Reviews Drug Discovery, 2011
exaly  

Practical, Legal, and Ethical Issues in Expanded Access to Investigational Drugs

New England Journal of Medicine, 2015
Jonathan Darrow, Ameet Sarpatwari, Aaron S Kesselheim   +2 more
exaly  

Access to investigational drugs in the USA

Lancet, The, 2007
exaly  

Drug repurposing: progress, challenges and recommendations

Nature Reviews Drug Discovery, 2018
Sudeep P Pushpakom, Francesco Iorio, Patrick A Eyers   +2 more
exaly